- ►ahajournals.org C Falcone, E Emanuele, A D'Angelo, MP Buzzi, … - Arteriosclerosis, thrombosis, and vascular biology, 2005 - Am Heart Assoc Methods and Results— Plasma levels of sRAGE were determined in 328 nondiabetic
male patients with angiographically proved CAD and in 328 age-matched healthy
controls. The concentration of sRAGE in plasma was significantly lower ... Cited by 112 - Related articles - All 11 versions
FC Sasso, O Carbonara, R Nasti, B Campana, R … - JAMA, 2004 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 64 - Related articles - BL Direct - All 5 versions
D Geroldi, C Falcone, E Emanuele, A D'Angelo … - Journal of hypertension, 2005 - journals.lww.com Objectives: Advanced glycation end-products (AGE) may cause vascular stiffening
by forming crosslinks through the collagen molecule or by interaction with their
cellular transductional receptor (RAGE). A secreted isoform of RAGE, termed ... Cited by 59 - Related articles - All 9 versions
- ►asnjournals.org R Meerwaldt, JWL Hartog, R Graaff, RJ … - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol Tissue advanced glycation end products (AGE) are a measure of cumulative
metabolic stress and trigger cytokines driven inflammatory reactions. AGE are
thought to contribute to the chronic complications of diabetes and ESRD. ... Cited by 59 - Related articles - BL Direct - All 6 versions
KCB Tan, WS Chow, S Tam, R Bucala, J … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Serum AGEs were increased in diabetic patients compared with control
subjects (4.24 ± 0.88 vs. 3.15 ± 0.81 unit/ml, respectively, P < 0.01). Both
plasma CRP (1.55 [0.81–2.95] vs. 0.88 mg/dl [0.51–1.89], respectively, ... Cited by 38 - Related articles - BL Direct - All 5 versions
JW Baynes - Clinical Chemistry and Laboratory Medicine, 2003 - reference-global.com Advanced glycation and lipoxidation end-products (AGE/ALE) increase in tissue
proteins with age and at an accelerated rate in diabetes. This Review focuses on
the nature and source of AGEs/ALEs and the factors af- fecting their ... Cited by 36 - Related articles - BL Direct - All 6 versions
S Yamagishi, H Adachi, K Nakamura, T Matsui, … - Metabolism, 2006 - Elsevier The advanced glycation end products (AGEs)-receptor for AGE (RAGE) axis is
implicated in diabetic vascular complications. Administration of soluble form of
RAGE (sRAGE) to mice has been shown to block the AGE-elicited tissue damage ... Cited by 36 - Related articles - All 17 versions
- ►ahajournals.org BK Kilhovd, A Juutilainen, S Lehto, T … - Arteriosclerosis, thrombosis, and vascular biology, 2005 - Am Heart Assoc Methods and Results— Serum levels of AGEs were measured with an immunoassay in
samples obtained at baseline examination of a random sample of 1141 nondiabetic
individuals (535 men and 606 women), aged 45 to 64 years, living in Kuopio, ... Cited by 37 - Related articles - All 7 versions
M Enomoto, H Adachi, S Yamagishi, M Takeuchi … - Metabolism, 2006 - Elsevier Advanced glycation end products (AGEs) are elevated in diabetes. We have
demonstrated that AGEs trigger thrombogenic responses in cultured cells. We
investigated here whether serum AGE levels were positively correlated with ... Cited by 19 - Related articles - All 15 versions
KC Tan, WS Chow, JC Lam, B Lam, R Bucala, J … - Sleep, 2006 - journalsleep.org ADVANCED GLYCATION ENDPRODUCTS (AGES) ARE A COMPLEX AND HETEROGENEOUS GROUP OF
COM- POUNDS THAT ARE FORMED WHEN REDUCING sugars, such as glucose, react
nonenzymatically with the amino groups through the Maillard reaction.1 ... Cited by 16 - Related articles - View as HTML - BL Direct - All 6 versions
